Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis

[1] Bakland G(2013)Epidemiology of spondyloarthritis: a review Curr Rheumatol Rep 15 351-76

[2] Nossent HC(2017)The paradox of bone formation and bone loss in ankylosing spondylitis: evolving new concepts of bone formation and future trends in management Curr Rheumatol Rep 19 17-919

[3] Magrey MN(2017)The immune dysfunction in ankylosing spondylitis patients BioSci Trends 11 69-140

[4] Khan MA(2016)IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection Clin Sci 130 907-541

[5] Duan Z(2010)CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients Immunity 32 129-604

[6] Gui Y(2011)Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells Blood 117 530-3893

[7] Li C(2013)CD19+CD24hiCD38hi B Cells maintain regulatory T cells while limiting TH1 and TH17 differentiation Sci Transl Med 5 173ra23-504

[8] Lin J(2018)Frequency of CD19+CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study Pediatr Rheumatol Online J 16 44-667

[9] Gober HJ(2017)Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis Immunol Res 65 592-95

[10] Qin J(2017)CD19+CD24hiCD38hi regulatory B cells are associated with insulin resistance in type I Hashimoto’s thyroiditis in Chinese females Exp Ther Med 14 3887-262

[1] Bakland G(2013)Epidemiology of spondyloarthritis: a review Curr Rheumatol Rep 15 351-76

[2] Nossent HC(2017)The paradox of bone formation and bone loss in ankylosing spondylitis: evolving new concepts of bone formation and future trends in management Curr Rheumatol Rep 19 17-919

[3] Magrey MN(2017)The immune dysfunction in ankylosing spondylitis patients BioSci Trends 11 69-140

[4] Khan MA(2016)IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection Clin Sci 130 907-541

[5] Duan Z(2010)CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients Immunity 32 129-604

[6] Gui Y(2011)Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells Blood 117 530-3893

[7] Li C(2013)CD19+CD24hiCD38hi B Cells maintain regulatory T cells while limiting TH1 and TH17 differentiation Sci Transl Med 5 173ra23-504

[8] Lin J(2018)Frequency of CD19+CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study Pediatr Rheumatol Online J 16 44-667

[9] Gober HJ(2017)Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis Immunol Res 65 592-95

[10] Qin J(2017)CD19+CD24hiCD38hi regulatory B cells are associated with insulin resistance in type I Hashimoto’s thyroiditis in Chinese females Exp Ther Med 14 3887-262